 Chronic rhinitis is affecting more than 200 million people worldwide. Its prevalence is estimated to be as high as 30 of the Western population. Rhinitis is defined as symptomatic inflammation of the inner lining of the nose and is characterized by the following symptoms: rhinorrhea, nasal blockage, nasal itching andor sneezing. The cut-off point for defining rhinitis as chronic rhinitis is considered to be persisting symptoms for over more than twelve weeks Chronic rhinitis can be divided into three major subgroups; based on the knowledge of the major etiological factor: infectious rhinitis, allergic rhinitis and non-allergic, non-infectious rhinitis, in literature also referred to as nonallergic rhinitis. Non-inferiority in efficacy of the two novel treatment regimes i.e. capsaicin nasal spray 0,01mM 2puffsnostrilday during 4 weeks and capsaicin nasal spray 0,001mM 2puffsnostrilday during 4 weeks compared to the current treatment of capsaicin nasal spray 0,1mM 5day administered on a single day with regard to the change from baseline in VAS for major nasal symptom on week 4. 